About Us - Galexia News
ABS accepts all recommendations in Galexia independent Privacy Impact Assessment (PIA) on National Health Survey (NHS) Linkage - 28 August 2018
|
Galexia has been engaged by the Australian Bureau of Statistics (ABS) to provide independent privacy advisory services.
Read more about Galexia’s work with ABS »
In April 2018, Galexia was engaged to provide an Independent Privacy Impact Assessment (PIA) to the Australian Bureau of Statistics (ABS) and Department of Health, examining the privacy considerations around the National Health Survey (NHS) Linkage Project.
In August 2018 this PIA was publicly released, and ABS has accepted all the recommendations.
The purpose of the PIA was to assist in identifying and managing privacy issues that are raised by the proposed integration of data between the 2014-15 NHS and MADIP (Multi-Agency Data Integration Project). While the NHS survey data was at a point in time (in this case collection took place between July 2014 and June 2015), MADIP data is longitudinal.
The key proposal was to:
1. Link the 2014-15 NHS data with a range of other data held in MADIP to facilitate research and statistical analysis; and
2. Ensure an effective governance framework for the proposed data integration (noting that NHS Linkage Governance will fall under MADIP Governance arrangements).
Galexia's advice included:
- Advising on the privacy issues associated with linking the 2014/15 NHS to the MADIP, including support for a targeted consultation process and conduct of an independent PIA.
- Identifying sub-populations for particular attention, and assess personal information and sensitive/less- sensitive variables;
- Providing general advice to inform the communication strategy for the project.
- Assisting ABS to apply learning from this process to inform its approach for future health surveys
In August 2018 this PIA was publicly released, and ABS has accepted all the recommendations.
- View PIA and ABS response » [Galexia - PDF]
- View ABS PIAs and responses » [External Link]
Read more about Galexia’s work with the ABS »